Abbott, Takeda Chemical sales and marketing update

ABT received exclusive marketing rights in Latin America to Takeda's Actos pioglitazone, a thiazolidinedione insulin-sensitizing agent to treat Type II diabetes. ABT expects to submit Latin American ...